The 8th Parkinson’s ‘Olympics’ targets key exercise habits
Health & Fitness
Author: Leszek DobrowolskiPublished: 20 August 2015
Prep: Cook: Serves:
Parkinsoniada sports games saw hundreds of people with Parkinson’s pick up the baton and get exercising, reports Leszek Dobrowolski, president of Warsaw Regional Association of People with Parkinson’s Disease
The eighth edition of Parkinsoniada took place in Czech Republic from 31 July to 2 August and attracted around 250 people with Parkinson’s – along with some affected by multiple sclerosis – to take part in the sports games.
Male and female players from the Czech Republic, Slovakia, Austria and Poland competed across 10 events, including table tennis, throwing, shots on goal (hockey or soccer), curling and bowling. Age is no obstacle at Parkinsoniada; one of the oldest participants was a Slovak man (87) and a Czech woman (80). In contrast, the youngest were in their 40s.
The opening ceremony began on the Friday in the main square in Hodonin, a town located very close to Brno, with speeches from Parkinsoniada founder, Jan Škrkal, and the mayor of Hodonin, Milana Grauové.
Let the games begin!
Parkinsoniada consists of 10 events:
throw in the basket
shot on goal with soccer ball
shot on goal with hockey stick
petang (pétanque- boccia)
shooting with digital shooting gun
shooting with blowpipe
Although I’ve attended Parkinsoniada before, the joy and energy that the patients – often despite severe disability – put into the competition made a great impression again. Their motivation to give their all from start to finish, trying to understand others despite the language barriers, while encouraging and comforting each other was lovely to see. Interestingly, those who looked less affected and more fit outwardly weren’t always the most successful. As usually the games were well organised, with the help of volunteers, and it culminated in the medal ceremony.
Everyone’s a winner
The greatest admiration is reserved for the perserance of all the participants in overcoming their condition. Particularly impressive was the fact that they attented this whole day event in the hot summer heat, and after a long time spent travelling the day before to reach Hodonin.
In between the events, there was always time for entertainment in the form of concerts by a female folk choir from Dubňany and the men’s choir from Dúbrava, of course, accompanied by dancing. The breaks are also an opportunity to meet and make contacts with patients, carers from other countries.
Every games is supported by an exhibition to raise awareness of the disease. This year it told the individual stories of those diagnosed at a young age.
This international meeting of people with Parkinson’s disease was founded by Jan Škrkal, president of Parkinson Slovácko o.s., who has lived with Parkinson’s for more than 10 years. The event’s principle aim is to support the will to overcome obstacles, to restore confidence in one’s own abilities and to develop the habit of regular exercise.
Download Parkinson’s app endorsed by José Mourinho
i-PROGNOSIS helps Parkinson's outcomes via patient data logging
3 days ago
Chemical used in dry cleaning may be associated with Parkinson’s disease
The chemical trichloroethylene (TCE) has been used across a number of industries: to decaffeinate coffee, degrease metal parts, remove stains and dry-clean clothing. It’s currently banned in the European Union and the US states New York and Minnesota, except for authorised industrial uses. Now, scientists led by Dr Ray Dorsey in the US have conducted new research claiming that TCE could be linked to an increased risk of Parkinson’s. Published in the ‘Journal of Parkinson’s Disease’, the study investigated case studies of seven people who were exposed to TCE prior to a Parkinson’s diagnosis – including basketball legend Brian Grant. The researchers “postulate that this ubiquitous chemical is contributing to the global rise of Parkinson’s and that TCE is one of its invisible and highly preventable causes”. They called for the cleaning of TCE-contaminated sites and for indoor air exposure to be diminished – as well as for further studies to be…
Could certain cancers be linked to Parkinson’s disease?
Previous research has suggested that people with Parkinson’s may generally be less likely to develop most cancers. However, a new international study has found a potential genetic link between certain types of cancer and the condition. The team analysed genetic data from genome-wide association studies – a research approach that aims to identify gene variations associated with disease risk – to recognise common genetic risk factors between cancer and Parkinson’s. The findings uncovered a genetic link between the condition and both prostate cancer and melanoma. Meanwhile, the sum of various gene variants (otherwise known as the polygenic risk score) that contribute to Parkinson’s was significantly associated with a higher risk of breast cancer. “Our results suggest the importance of shared genetic variants between Parkinson’s and some cancers,” the researchers concluded in the study, which was published in the medical journal ‘Movement Disorders’. They highlighted the need for further studies to…
Investigational Parkinson’s disease dementia therapy fails in clinical trial
Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…